Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes.

The anti-melanoma monoclonal antibody HMB45 is widely used in diagnostic pathology owing to its great specificity and sensitivity in identifying pigmented tumors such as malignant melanoma. However, little is known regarding the nature of the antigen(s) recognized by this antibody. In the observations reported here, the HMB45-defined antigen was identified in another pigmented tissue, the retinal pigment epithelium (RPE). A series of immunocytochemical studies demonstrated transient reactivity of the prenatal and infantile human RPE with antibody HMB45; adult RPE is non-reactive with the antibody. By immunoelectron microscopy, the antibody was demonstrated to react with immature melanosomes. Pre-treatment of deparaffinized tissue sections with neuraminidase completely eliminated HMB45 immunoreactivity, suggesting that the antigen(s) recognized is a sialated glycoconjugate. Mannosidase or N-acetylglucosaminidase pre-treatment had no effect on immunoreactivity. Thus, HMB45 may identify an oncofetal antigen present in cutaneous melanocytes, RPE, and melanoma cells, and changes in immunoreactivity with maturation or malignant transformation may be a function of post-translational modification.

[1]  G. Zamboni,et al.  Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast. , 1989, American journal of clinical pathology.

[2]  M. Melamed,et al.  Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. , 1985, Cancer research.

[3]  R. Gorlin,et al.  Melanotic Neuroectodermal Tumor of Infancy: A Reexamination of a Histogenetic Problem Based on Immunohistochemical, Flow Cytometric, and Ultrastructural Study of 10 Cases , 1991, The American journal of surgical pathology.

[4]  K. Holbrook,et al.  Melanocytes in Human Embryonic and Fetal Skin: A Review and New Findings , 1988 .

[5]  X. Ji,et al.  Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. , 1988, American journal of clinical pathology.

[6]  A. Gown,et al.  Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. , 1986, The American journal of pathology.

[7]  E. Reynolds.  THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY , 1963, The Journal of cell biology.

[8]  F. Moyer.  GENETIC EFFECTS ON MELANOSOME FINE STRUCTURE AND ONTOGENY IN NORMAL AND MALIGNANT CELLS * , 1963 .

[9]  A. Cochran,et al.  Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma. , 1979, The British journal of dermatology.

[10]  A. Gown,et al.  False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of antimelanoma monoclonal antibody HMB45. , 1991, American journal of clinical pathology.

[11]  A. Houghton,et al.  Cell surface antigens of melanocytes and melanoma. , 1985, Cancer surveys.

[12]  G. Edelman,et al.  Embryonic to adult conversion of neural cell adhesion molecules in normal and staggerer mice. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. S. Fine,et al.  Light and electron microscopic observations on the pigmented layers of the developing human eye. , 1972, American journal of ophthalmology.

[14]  K. Jimbow,et al.  Fine structural characterization of melanosomes in dysplastic nevi , 1985, Cancer.

[15]  F. Real,et al.  Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. , 1988, The Journal of investigative dermatology.

[16]  D. Galloway,et al.  Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. , 1981, Hybridoma.

[17]  K. Jimbow,et al.  Development of MoAB HMSA‐2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes , 1987, Cancer.

[18]  F. Beck,et al.  Developmental Stages in Human Embryos. , 1988 .

[19]  G. Edelman,et al.  Differences in the carbohydrate structures of neural cell-adhesion molecules from adult and embryonic chicken brains. , 1982, The Journal of biological chemistry.

[20]  A. Gown,et al.  Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications. , 1986, American journal of surgery.

[21]  G. Imokawa.  Analysis of carbohydrate properties essential for melanogenesis in tyrosinases of cultured malignant melanoma cells by differential carbohydrate processing inhibition. , 1990, The Journal of investigative dermatology.

[22]  R. Kapur,et al.  Ultrastructural evidence that specialized regions of the murine oviduct contribute a glycoprotein to the extracellular matrix of mouse oocytes , 1988, The Anatomical record.